Literature DB >> 2160596

Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma.

M Frohlich1, P Motté, K Galvin, H Takahashi, J Wands, M Ozturk.   

Abstract

A basic phosphoprotein defined by a monoclonal antibody named AF5 was found to be highly abundant in human hepatocellular carcinoma by Western immunoblotting. Under the same conditions, the levels of this phosphoprotein were low or undetectable in normal liver extracts. The AF5 antibody was used to screen a cDNA expression library of a human hepatoma cell line named FOCUS. A 960-base-pair cDNA was isolated and found to be a partial cDNA encoding the human protein-tyrosine kinase substrate p36, also known as lipocortin II. p36 expression was highly abundant in hepatocellular carcinomas at both the transcript and protein levels. Its expression was not induced significantly during rat liver regeneration following a partial hepatectomy. These results suggest that the induction of p36 expression is associated with malignant transformation of hepatocytes. p36 was previously shown to be phosphorylated upon transformation of normal fibroblasts by retroviral oncogenes without significant modulation of expression. We report here the initial description of the association of increased p36 expression with malignant transformation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160596      PMCID: PMC360686          DOI: 10.1128/mcb.10.6.3216-3223.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  Transformation by Rous sarcoma virus: effects of src gene expression on the synthesis and phosphorylation of cellular polypeptides.

Authors:  K Radke; G S Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

2.  Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.

Authors:  B Bressac; K M Galvin; T J Liang; K J Isselbacher; J R Wands; M Ozturk
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Transformation by Rous sarcoma virus: a cellular substrate for transformation-specific protein phosphorylation contains phosphotyrosine.

Authors:  K Radke; T Gilmore; G S Martin
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

5.  Evidence that viral transforming gene products and epidermal growth factor stimulate phosphorylation of the same cellular protein with similar specificity.

Authors:  E Erikson; D J Shealy; R L Erikson
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

6.  Identification of a cellular protein substrate phosphorylated by the avian sarcoma virus-transforming gene product.

Authors:  E Erikson; R L Erikson
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

7.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

8.  Identification and characterization of cellular targets for tyrosine protein kinases.

Authors:  J A Cooper; T Hunter
Journal:  J Biol Chem       Date:  1983-01-25       Impact factor: 5.157

9.  The 46,000-dalton tyrosine protein kinase substrate is widespread, whereas the 36,000-dalton substrate is only expressed at high levels in certain rodent tissues.

Authors:  K L Gould; J A Cooper; T Hunter
Journal:  J Cell Biol       Date:  1984-02       Impact factor: 10.539

10.  Changes in the distribution of the 34-kdalton tyrosine kinase substrate during differentiation and maturation of chicken tissues.

Authors:  M E Greenberg; R Brackenbury; G M Edelman
Journal:  J Cell Biol       Date:  1984-02       Impact factor: 10.539

View more
  19 in total

1.  Specific down-regulation of annexin II expression in human cells interferes with cell proliferation.

Authors:  Y Chiang; A Rizzino; Z A Sibenaller; M S Wold; J K Vishwanatha
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

2.  The major histocompatibility complex class I antigen-binding protein p88 is the product of the calnexin gene.

Authors:  K Galvin; S Krishna; F Ponchel; M Frohlich; D E Cummings; R Carlson; J R Wands; K J Isselbacher; S Pillai; M Ozturk
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

Review 3.  Annexins: calcium-binding proteins of multi-functional importance?

Authors:  J Römisch; E P Pâques
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

4.  Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.

Authors:  Jocelyn Stewart; Neil Fleshner; Heather Cole; Joan Sweet
Journal:  J Clin Pathol       Date:  2006-08-17       Impact factor: 3.411

5.  Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress.

Authors:  T Tanaka; S Kondo; Y Iwasa; H Hiai; S Toyokuni
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

Review 6.  Role of Annexin-II in GI cancers: interaction with gastrins/progastrins.

Authors:  Pomila Singh
Journal:  Cancer Lett       Date:  2006-12-22       Impact factor: 8.679

7.  Effect of shRNA mediated down-regulation of Annexin A2 on biological behavior of human lung adencarcinoma cells A549.

Authors:  Yue-xiang Wang; Hui Lv; Ze-xia Li; Cui Li; Xiao-ying Wu
Journal:  Pathol Oncol Res       Date:  2011-06-18       Impact factor: 3.201

8.  Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma.

Authors:  L Lavaissiere; S Jia; M Nishiyama; S de la Monte; A M Stern; J R Wands; P A Friedman
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

9.  Annexin II up-regulates cellular levels of p11 protein by a post-translational mechanisms.

Authors:  A Puisieux; J Ji; M Ozturk
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

10.  Annexin II represents metastatic potential in clear-cell renal cell carcinoma.

Authors:  Y Ohno; M Izumi; T Kawamura; T Nishimura; K Mukai; M Tachibana
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.